CAPTRUST FINANCIAL ADVISORS - BIONDVAX PHARMACEUTICALS LTD ownership

BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 18 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of BIONDVAX PHARMACEUTICALS LTD
ValueSharesWeighting
Q2 2022$1,000
-50.0%
1,0000.0%0.00%
Q1 2022$2,0000.0%1,0000.0%0.00%
Q4 2021$2,0000.0%1,0000.0%0.00%
Q3 2021$2,000
-33.3%
1,000
-16.0%
0.00%
Q2 2021$3,000
-40.0%
1,1900.0%0.00%
Q1 2021$5,000
+66.7%
1,1900.0%0.00%
Q4 2020$3,000
-93.6%
1,1900.0%0.00%
-100.0%
Q3 2020$47,0001,1900.00%
Other shareholders
BIONDVAX PHARMACEUTICALS LTD shareholders Q2 2021
NameSharesValueWeighting ↓
TRUE Private Wealth Advisors 55,500$64,0000.01%
Aspire Private Capital, LLC 1,600$2,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 4,692$5,0000.00%
Global Retirement Partners, LLC 500$1,0000.00%
CREDIT AGRICOLE S A 4,240$5,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 13,768$16,0000.00%
ENVESTNET ASSET MANAGEMENT INC 163,423$191,0000.00%
Citadel Advisors 23,844$28,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,138$13,0000.00%
View complete list of BIONDVAX PHARMACEUTICALS LTD shareholders